euroPLX Boosts Pharma Business Development in Difficult Times

Malta partnering event with record attendance. Next euroPLX event filling rapidly. (more)

Medial Cyclotron opens at Lawson and St. Joseph's Health Care, London

This new facility is instrumental in providing patients with the most advanced medical diagnostic imaging technology available today, and will allow London researchers to perform cutting edge medical research. (more)

Protecting the brain from a deadly genetic disease

Huntington's disease (HD) is a cruel, hereditary condition that leads to severe physical and mental deterioration, psychiatric problems and eventually, death. Currently, there are no treatments to slow down or stop it. (more)

Shulich professor earns gold medal for liver disease research

Lawson Health Research Institute scientist and Schulich School of Medicine & Dentistry professor Paul Adams may not be at the Olympics in Vancouver, but he earned himself a gold medal in the area of liver disease research. (more)

Business Developers From 37 Countries Will Convene in Malta

euroPLX 42 Valletta attracts more than 200 delegates from 37 countries. (more)

PronovaMedical launches unique anti head lice range!

A unique anti head lice range called Licatack will be launched worldwide by PronovaMedical. The company has succeeded in developing a complete anti head lice range, including a unique treatment, a preventive spray and an innovative lice and nits comb. (more)

Penwest Initiates Second Phase IIa Clinical Trial for A0001

Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has initiated a Phase IIa clinical trial for A0001 in patients with the A3243G mitochondrial DNA point mutation and evidence of impaired mitochondrial function. (more)

Western appoints next Dean of Schulich Medicine & Dentistry

The University of Western Ontario has announced the appointment of Dr. Michael J. Strong as Dean of the Schulich School of Medicine & Dentistry. Dr. Strong will begin his term as Dean on July 1, 2010 and will serve until June 30, 2015. (more)

Studying heart failure of mice and men

Scientists at Robarts Research Institute, working in collaboration with researchers in Brazil, have used a unique genetically-modified mouse line to reveal a previously unidentified mechanism contributing to heart failure. (more)

New collaboration presents big opportunities for UK SMEs

The recent signing of a co-promotional agreement between myM-link and Medical Device Licensing (a division of UTEK Europe, Ltd.), whereby myM-link will actively promote partnering opportunities from Medical Device Licensing’s client companies directly to (more)